US Broker Ratings

LivaNova PLC (LIVN) Stock Analysis: Exploring a 19.75% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, LivaNova PLC (LIVN) presents an intriguing proposition. This United Kingdom-based medical technology company, with a market capitalization of $2.96 billion, specializes in..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating a Complex Valuation with a 27.65% Potential Downside

GRAIL, Inc. (NASDAQ: GRAL), a prominent player in the healthcare sector, is making significant strides in the diagnostics and research industry. Headquartered in Menlo Park, California, GRAIL is renowned for..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Potential 105% Upside in the Biotech Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, has recently captured the attention of investors with a market cap of $1.94 billion and a promising pipeline..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A Lucrative Upside of 20.69% Amidst Robust Revenue Growth

Travere Therapeutics, Inc. (NASDAQ: TVTX) is drawing significant attention from investors in the biotechnology sector, with a current market capitalization of $2.65 billion. As a key player in the healthcare..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 15% Growth Potential in the Healthcare Sector

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has emerged as a notable player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Unlocking a 26% Potential Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the healthcare sector, particularly within the biotechnology industry. With a market cap of $3.88 billion, this San Diego-based company has carved a..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Analyzing a Potential 125% Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical company specializing in therapies for muscle disorders, is drawing significant attention from investors, not least due to its impressive potential upside of 125.54%...

CRISPR Therapeutics AG (CRSP) Investor Outlook: Exploring a 26.22% Potential Upside in the Gene-Editing Frontier

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneer in the gene-editing sector, offers a fascinating opportunity for investors who are willing to navigate the volatile waters of biotechnology. With a market..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating the 9.95% Potential Upside

Ascentage Pharma Group International (NYSE: AAPG), a clinical-stage biotechnology company headquartered in Suzhou, China, is making waves in the healthcare sector. Despite facing significant challenges, including a revenue decline of..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Navigating a 74% Upside Potential with Biotech Innovation

Beam Therapeutics Inc. (NASDAQ: BEAM), a prominent player in the biotechnology sector, is making waves with its cutting-edge precision genetic medicines. Based in Cambridge, Massachusetts, Beam Therapeutics focuses on addressing..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a 15.59% Potential Upside in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, has caught the attention of investors with its intriguing potential upside of 15.59%. Known for its diversified..

Azenta, Inc. (AZTA) Investor Outlook: Analyzing the 6.13% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA) stands as a compelling player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.46 billion, this Burlington,..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 35.96% Potential Upside in the Healthcare Sector

Pacira BioSciences, Inc. (NYSE: PCRX) continues to capture investor interest with its specialized focus on non-opioid pain management solutions. With a market capitalization of approximately $958.41 million, Pacira operates in..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Its 14.27% ROE in a Challenging Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD) may not be a household name, but for investors seeking exposure to the healthcare sector, this medical care facilities company offers an interesting proposition...

Dynavax Technologies (DVAX) Stock Analysis: Exploring a 117% Potential Upside with Strong Revenue Growth

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.23 billion, the company..

Omnicell, Inc. (OMCL)

⚠️ No article content returned.

..

Supernus Pharmaceuticals, Inc. (SUPN) Investor Outlook: Potential Upside and Analyst Ratings Signal Growth Prospects

Supernus Pharmaceuticals, Inc. (SUPN) has emerged as a noteworthy player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Headquartered in Rockville, Maryland, this biopharmaceutical..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Capitalizing on a 155% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is garnering significant attention in the biotechnology sector, with its promising pipeline of novel oral small molecule therapeutics aimed at addressing chronic diseases with unmet..

Envista Holdings Corporation (NVST) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Ratings

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $3.38 billion, this..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 16.86% Potential Upside in Medical Devices

For investors with a keen eye on the healthcare sector, Alphatec Holdings, Inc. (NASDAQ: ATEC) presents an intriguing opportunity. Specializing in medical devices, particularly for spinal disorder treatments, Alphatec has..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds